You are here

  • Home
  • Archive
  • Volume 59, Issue 7
  • Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Now and then
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis

Authors

  • Josef S Smolen aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Ferdinand C Breedveld aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Gerd R Burmester aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Bernard Combe aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Paul Emery aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Joachim R Kalden aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Lars Klareskog aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Ravinder N Maini aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Raffele Numo aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Leo B A van de Putte aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Piet L C M van Riel aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  • Vicente Rodriguez-Valverde aUniversity of Vienna, bUniversity of Leiden, cUniversity of Charité, Berlin, dUniversity of Montpellier, eUniversity of Leeds, fUniversity of Erlangen, gUniversity of Stockholm, hUniversity of Charing Cross, London, iUniversity of Bari, jUniversity of Nijmegen, kUniversity of Cantabria PubMed articlesGoogle scholar articles
  1. Dr Josef S Smolen, Division of Rheumatology, Department of Internal Medicine III, University of Vienna, Vienna General Hospital, Waehringer Guertel 18–20, A-1090 Vienna, Austria Email: smj{at}2me.khl.magwien.gv.at
View Full Text

Citation

Smolen JS, Breedveld FC, Burmester GR, et al
Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis
Annals of the Rheumatic Diseases 2000;59:504-505.

Publication history

  • Accepted May 4, 2000
  • First published July 1, 2000.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases